Mobile

A double-blind, randomised, placebo-controlled, multi-centre study to assess the efficacy and safety of adjunctive zonisamide in myoclonic seizures associated with idiopathic generalised epilepsy. E...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-003556-10

A double-blind, randomised, placebo-controlled, multi-centre study to assess the efficacy and safety of adjunctive zonisamide in myoclonic seizures associated with idiopathic generalised epilepsy. Estudio en doble ciego, aleatorizado, controlado con placebo y multicéntrico, dirigido a evaluar la eficacia y la seguridad del tratamiento adyuvante con zonisomida en las crisis mioclónicas asociadas a la epilepsia generalizada idiopática

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The objective of this trial is to assess the efficacy of adjunctive zonisamide in IGE in reducing the frequency of myoclonic seizures in subjects with continuing seizures despite treatment with one or two other anti-epileptic drugs (AEDs).

Critère d'inclusion

  • Crisis mioclónicas en epilepsia generalizada idiopática,Myoclonic seizures in idiopatic generalized epilepsy (IGE)

Liens